6 articles with Grifols
Grifols Achieves Key Milestone with FDA Approval of the New Consolidated Manufacturing Facility (CMF) for Production of Recombinant Proteins
The new facility, equipment, and automation systems ensure reliable production of antigens for blood supply safety and patient health.
Grifols Procleix Ultrio Elite assay screens for HIV-1, HCV, and HBV and detects HIV-2; the Procleix WNV assay screens for West Nile virus
- The Daratumumab neutralization testing service from Grifols, will allow improved management of patients under Daratumumab treatment requiring transfusion - Test will be offered at Grifols Immunohematology Center in San Marcos, Texas
Grifols conventional antisera reagents recently received licensing approval by the U.S. Food & Drug Administration for manual testing in immunohematology laboratories.
Part of an eight-year commitment to WFH; Changing the lives of people with hemophilia in 47 countries with limited access to treatment
Grifols announced that it has filed its 2017 Annual Report on Form 20-F with the United States Securities and Exchange Commission ("SEC") on April 6, 2018.